We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Essential TB Protein Detected in Clinical Sputum Samples

By LabMedica International staff writers
Posted on 19 Jan 2009
A tuberculosis (TB) marker was detected in clinical strains of the bacteria responsible for TB as well as in clinical sputum samples. More...


TB is difficult to diagnose and current diagnosis generally relies on an insensitive 100-year-old technique of smear microscopy. The TB diagnostic market lacks a simple, rapid, and cost effective test to accurately identify TB. The rapid assays developed to date rely on the detection of a human response to TB infection. The disease causes high mortality in developing countries and is a leading cause of death among people infected with human immunodeficiency virus (HIV).

Approximately one third of the world's population, or 2 billion people, have been exposed to the TB pathogen causing about 9 million infections and 2 million deaths annually. While TB is predominantly a disease of developing countries (718 cases per 100,000 people in South Africa), the incidence in developed countries has risen significantly (13 per 100,000 in the United States), due to the global spread of HIV and increased immigration and travel. Coinfection with HIV is a particular problem for accurate diagnosis of TB and for compromising the effectiveness of the antiretroviral drugs used to treat HIV.

Tyrian Diagnostics (Sydney, Australia) identified proteins from the bacteria that cause TB--Mycobacterium tuberculosis--circulating in blood and/or sputum in people diagnosed with the disease. The company has competed Milestone 4 of a feasibility study in collaboration with Becton, Dickinson and Company (BD; Franklin Lakes, New Jersey, USA) to determine the suitability of Tyrian's TB protein markers for the development of rapid diagnostic tests to detect active TB disease.

The study demonstrated detection of selected TB proteins in sputum. Methods for sample preparation and testing suitable for use in the field were developed. Tyrian identified a lead marker that appears to be particularly suitable for a diagnostic test because it is an essential TB protein, meaning that it is always present when there is active TB. In an adjunct study, Tyrian demonstrated that this same marker could also be developed as a molecular diagnostic assay.

"This collaborative study with BD has identified two potential products for development using our lead marker," said Jenny Harry, CEO of Tyrian Diagnostics. "A molecular diagnostic test could be developed, using existing gene expression technology, for primary use in hospitals, clinics, and analytical, and research laboratories. Secondly, an antigen-based Point-of-Care test would address a broader market by providing an immediate result without the need for laboratory facilities."

Related Links:
Tyrian Diagnostics



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.